University of Massachusetts Medical School researcher Victor Ambros and Massachusetts General Hospital investigator Gary Ruvkun have received the 2012 Dr. Paul Janssen Award for Biomedical Research for their co-discovery of microRNAs.
Ambros' lab discovered the first miRNA, while Ruvkun's lab independently identified how these small, non-coding RNAs regulate their target mRNA, according to Johnson & Johnson, which sponsors the award.
“Working together, they demonstrated that the miRNA inactivates its target through direct, base-pairing interactions,” the company said.
RXi Pharmaceuticals has appointed Robert Bitterman and Keith Brownlie to its board of directors.
Bitterman is currently the president and CEO of Cutanea Life Sciences, and Brownlie previously worked as metro New York area life sciences industry leader for Ernst & Young.